Open Innovation A Must, Not A Choice: Hanmi Forum
This article was originally published in PharmAsia News
Executive Summary
Hanmi Pharm has convened a forum in Seoul to discuss open innovation from various perspectives and to explore R&D directions and partnering strategies fit for South Korea's wider pharma industry, and to identify the main challenges along the way. Through the initiative, the firm is aiming to share R&D ideas, bolster its pipeline and seek ways to cooperate with industry, academia and research institutes.